Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series.

Saved in:
Bibliographic Details
Title: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series.
Authors: Naqash AR; Department of Medicine, Division of Hematology/Oncology, Vidant Cancer Center at East Carolina University, 600 Moye Blvd, Greenville, NC, 27834, USA. Naqasha16@ecu.edu., File DM; Department of Medicine, Division of Hematology/Oncology, University of North Carolina, 170 Manning Drive, Chapel Hill, NC, 27599, USA., Ziemer CM; Department of Dermatology, University of North Carolina, Chapel Hill, NC, 27516, USA., Whang YE; Department of Medicine, Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, 170 Manning Drive, Chapel Hill, NC, 27599, USA., Landman P; UNC Health Care, The University of North Carolina, 170 Manning Drive, Chapel Hill, NC, 27599, USA., Googe PB; Department of Dermatology, Pathology and Laboratory Medicine, University of North Carolina School of Medicine, 250 Bell Tower Drive CB#7287, Chapel Hill, NC, 27599, USA., Collichio FA; Department of Medicine, Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, 170 Manning Drive, Chapel Hill, NC, 27599, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Jan 08; Vol. 7 (1), pp. 4. Date of Electronic Publication: 2019 Jan 08.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1186/s40425-018-0475-y